<p>Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, and <em>Pseudomonas aeruginosa</em> isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.